Advertisement
U.S. markets closed

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
92.57-1.27 (-1.35%)
At close: 04:00PM EDT
95.06 +2.49 (+2.69%)
After hours: 06:07PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close93.84
Open93.50
Bid92.47 x 100
Ask92.59 x 200
Day's Range92.45 - 94.64
52 Week Range73.68 - 99.56
Volume2,005,961
Avg. Volume2,382,695
Market Cap17.624B
Beta (5Y Monthly)0.32
PE Ratio (TTM)70.13
EPS (TTM)1.32
Earnings DateOct 30, 2024 - Nov 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est109.39
  • PR Newswire

    BioMarin Announces New R&D and Business Development Leadership

    BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced the appointments of Greg Friberg, M.D., as Executive Vice President, Chief Research & Development Officer, succeeding Hank Fuchs, M.D., and James Sabry, M.D., Ph.D., as Executive Vice President, Chief Business Officer.

  • BioPharma Dive

    BioMarin taps Amgen, Roche vets in executive reshuffle

    Greg Friberg and James Sabry will take over, respectively, as heads of R&D and business development, less than a year after BioMarin named a new CEO.

  • PR Newswire

    BioMarin to Host 2024 Investor Day on September 4th in New York

    BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an Investor Day with financial analysts and institutional investors on Wednesday, September 4, 2024, in New York City from 10:30 am to 1:00 pm Eastern Time. The event will feature presentations from members of the executive management team and will highlight BioMarin's pipeline, strategic plans, growth opportunities and long-term financial outlook.